Lumida
/CBNK
⌘K
Capital Bancorp Inc

Capital Bancorp Inc

CBNK
$36.25USD↓-0.30%-0.11 today

MARKET CAP

590.5M

P/E (TTM)

10.7x

FWD P/E

—

DAY RANGE

$36 – $37

52W RANGE

$26
$39

AI Summary

Stalk
StalkMedium

CBNK remains in a clear Stage 2 advance within a persistent uptrend and a fresh Momentum Breakout signaling institutional demand. However, price is extended above rising EMAs and sits in extreme overbought territory, suggesting timing is unfavorable now. Preferred engagement is deferred: wait for a pullback into the 9/21EMA cluster or prior resistance-turned-support. A breakdown below these EMAs would undermine the bullish conviction.

  • ↑Earnings yield 1.62% and ROA of 1.52% indicate strong profitability
  • ↑ROTCE at 15.3% demonstrates efficient capital utilization
  • ↓Limited scale and low liquidity deter larger investors
Full analysis →

Buying

6

institutions

Selling

2

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕Action↕Shares Held↕Value↓Change↕Chg %↕Weight↕
BI

Blackrock, Inc.

Q2 2026

BUY786.59 K27.62 M+64.58 K+28.6%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUY102.33 K3.59 M+7.70 K+27.7%0.00%
MG

Man Group Plc

Q2 2026

BUY56.02 K1.97 M+22.64 K+98.2%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUY47.92 K1.68 M+34.75 K+329.8%0.00%
MM

Millennium Management LLC

Q2 2026

BUY46.03 K1.62 M+14.27 K+71.2%0.00%
RT

Renaissance Technologies LLC

Q2 2026

BUYNEW16.50 K579.48 K+16.50 K+0.0%0.00%
AC

Arcus Capital Partners, LLC

Q2 2026

SELL12.86 K451.71 K+-8.14 K-27.7%0.19%
JC

Jpmorgan Chase & Co

Q2 2026

SELL5.36 K188.17 K+-318.00+12.1%0.00%